P2X7-receptor binding in new-onset and secondary progressive MS - a [11C]SMW139 PET study

Jussi Lehto1,2,3, Richard Aarnio4, Jouni Tuisku4

  • 1Turku PET Centre, Turku, Finland. juleht@utu.fi.

EJNMMI Research
|December 5, 2024
PubMed
Abstract

Insights

Positron emission tomography (PET) imaging revealed no significant difference in P2X7 receptor binding in the MS brain compared to healthy controls. However, tracer binding varied by lesion proximity, patient sex, and disease duration.

Area of Science:

  • Neuroimaging
  • Neuroinflammation
  • Multiple Sclerosis (MS)

Background:

  • Activated microglia, particularly at smoldering lesion rims, are implicated in MS disability progression.
  • The P2X7 receptor (P2X7R) is upregulated on activated microglia.
  • PET imaging offers a window into microglial activation in MS.

Purpose of the Study:

  • To quantify P2X7R binding in the brains of progressive MS patients, relapsing MS patients, and healthy controls using a dual-input model.
  • To investigate the relationship between P2X7R binding and MS pathology, including lesion proximity, disease duration, sex, and age.

Main Methods:

  • Application of a single-tissue dual-input model for P2X7R quantification.
  • PET imaging was performed on progressive MS patients, relapsing MS patients, and healthy controls.
  • Analysis included normal-appearing white matter, perilesional areas, and thalamus.

Main Results:

  • Overall tracer uptake in MS brains was not significantly higher than in healthy controls.
  • Tracer binding was higher in the perilesional rim of T1 lesions in relapsing MS patients compared to progressive MS patients.
  • Tracer binding was higher in males than females, and correlated with disease duration in normal-appearing white matter and negatively with age in perilesional rims.

Conclusions:

  • While binding estimates aligned with expected P2X7R distribution, the parent tracer's small free fraction may affect accuracy and applicability.
  • High variability in binding estimates between subjects was observed.
  • Conclusive evidence for using [11C]SMW139 to detect diffuse smoldering inflammation in MS was not established.